샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774870

세계의 소화관 출혈 치료 시장

Gastrointestinal Bleeding Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 471 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 소화관 출혈 치료 시장은 2030년까지 12억 달러에 이를 전망

2024년에 8억 4,590만 달러로 추정되는 소화관 출혈 치료 세계 시장은 분석 기간인 2024-2030년 CAGR 5.9%로 성장하여 2030년에는 12억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 내시경 지혈 기기는 CAGR 4.7%를 나타내고, 분석 기간 종료시에는 7억 480만 달러에 이를 것으로 예측됩니다. 봉합 장치 분야의 성장률은 분석 기간중 CAGR 8.0%로 추정됩니다.

미국 시장은 2억 3,050만 달러로 추정, 중국은 CAGR 9.0%로 성장 예측

미국의 소화관 출혈 치료 시장은 2024년에 2억 3,050만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 9.0%로 성장을 지속하여, 2030년에는 2억 3,880만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.0%와 5.7%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%로 성장할 전망입니다.

세계의 소화관 출혈 치료 시장 - 주요 동향과 촉진요인 정리

왜 소화관 출혈 치료는 점점 더 발전하고 효과적일까요?

소화관(GI) 출혈의 치료는 진단 기술, 최소 침습 수술, 표적 약리 요법의 발전으로 최근 몇 년 동안 크게 발전해 왔습니다. 상부 또는 하부 소화관에서 발생할 수 있는 소화관 출혈은 생명을 위협하는 합병증을 예방하기 위해 신속한 진단과 개입이 필요한 심각한 질환입니다. 가장 흔한 원인은 소화성 궤양, 게실증, 염증성 장질환(IBD), 식도 정맥류, 대장암 등입니다.

세계 인구의 고령화와 함께 소화기 질환의 유병률 증가는 효과적인 치료 솔루션에 대한 수요를 증가시키고 있습니다. 클립삽입, 아르곤 플라즈마 응고(APC), 주입 요법과 같은 내시경적 지혈 기술은 대부분의 경우 활동성 출혈을 조절하는 데 있어 표준이 되고 있습니다. 또한, 내시경 영상 진단에 인공지능(AI)을 통합하여 출혈 원인을 조기에 발견하고 환자 예후를 개선하고 있습니다. 의료 서비스 제공업체들이 첨단 치료법을 계속 채택함에 따라, 소화관 출혈 관리 환경은 더 빠르고, 더 안전하고, 더 효율적인 개입으로 변화하고 있습니다.

어떤 치료법이 소화관 출혈 관리의 혁신을 주도하고 있는가?

소화관 출혈의 관리는 내시경적, 약리학적, 외과적 개입을 결합하여 혁명적으로 변화하고 있습니다. 내시경 시술은 여전히 급성 위장관 출혈의 주요 치료법이며, 열응고법, 밴드 결찰법, 지혈 스프레이 기술 등이 즉각적인 지혈을 제공합니다. 캡슐내시경과 심부주입내시경은 기존 내시경 검사로 진단하기 어려웠던 소장의 불명확한 소화관 출혈의 진단 및 치료 능력을 향상시키고 있습니다.

양성자펌프억제제(PPI), 혈관확장제, 트라넥삼산 등의 약물 치료는 재출혈을 예방하고 기저질환을 관리하는 데 중요한 역할을 합니다. 심한 경우 경동맥 색전술(TAE)과 같은 중재적 방사선 시술은 내시경적 시술이 효과가 없는 경우 출혈을 조절하기 위해 사용됩니다. 난치성 소화관 출혈에 대해서는 대장 부분 절제술이나 위 절제술과 같은 수술적 치료가 필요합니다. 내시경적 치료와 약리학적 치료를 통합한 병용요법의 채택이 증가하고 있으며, 환자의 전체 생존율이 향상되고 입원비용이 감소하고 있습니다.

기술의 발전은 어떻게 소화관 출혈 치료를 개선하고 있는가?

최근 몇 년간의 기술 발전은 소화관 출혈의 진단, 치료 및 예방을 크게 향상시켰으며, AI를 이용한 내시경 검사는 가장 혁신적인 기술 혁신 중 하나로 실시간 이미지 분석 및 출혈 병변의 자동 검출을 가능하게 합니다. 이 기술은 의사의 정확도를 높이고, 시술 시간을 단축하며, 고위험 병변의 조기 발견을 개선합니다. 또한, 분무형 생물학적 제제 및 생체 흡수성 지혈제를 포함한 첨단 지혈제의 개발로 복잡한 출혈 사례에 대한 치료 옵션이 확대되었습니다.

또 다른 획기적인 발전은 로봇 보조 내시경의 사용입니다. 로봇 보조 내시경은 소화관의 접근이 어려운 부위를 치료할 때 더 높은 정확도와 조작성을 제공합니다. 스마트 캡슐 내시경 역시 진정제나 방사선 노출 없이 소장의 비침습적 시각화를 가능하게 하여 인기를 얻고 있습니다. 또한, 유전자 치료와 재생 의학의 발전은 환자가 출혈이 재발하기 쉬운 만성 소화기 질환을 치료하기 위해 연구되고 있습니다. 이러한 기술 혁신은 환자 결과와 의료 효율성을 개선하고 소화관 출혈 관리의 미래를 재구성하고 있습니다.

소화관 출혈 치료 시장의 성장을 가속하는 요인은 무엇인가?

소화관 출혈 치료 시장의 성장은 GI 질환의 유병률 증가, 첨단 내시경 기술의 채택 증가, 최소 침습적 치료 옵션의 확대 등 여러 요인에 의해 발생합니다. 특히 선진국에서는 고령화, 소화성 궤양, 게실증, 식도 정맥류의 발생률이 높아지면서 소화관 출혈의 원인이 되고 있습니다.

AI 지원 내시경, 로봇 수술, 지혈 생체 재료와 같은 기술 혁신은 소화관 출혈 치료의 효과를 높이고 의료 서비스 제공업체의 채택을 촉진하고 있습니다. 또한, 외래수술센터(ASC) 및 외래수술센터(ASC)의 확장으로 환자의 최소 침습 수술에 대한 접근성이 향상되고 입원 필요성이 감소하고 있습니다. 또한, 대장암 및 소화기 질환에 대한 조기 검진 및 진단 프로그램을 장려하는 정부의 이니셔티브는 시장 성장을 더욱 촉진하고 있습니다. 효과적이고 덜 침습적인 소화관 출혈 치료에 대한 수요가 지속적으로 증가함에 따라 의료 기술의 지속적인 발전과 환자 중심의 치료 솔루션이 시장 확대를 견인할 것으로 예측됩니다.

부문

제품 (내시경 지혈 장치, 폐쇄 장치, 기타 제품); 위장관 부문 (상부 위장관, 하부 위장관); 발병 (급성 발병, 만성 발병); 최종 용도 (병원 최종 용도, 외래 수술 센터 최종 용도, 기타 최종 사용자)

조사 대상 기업 예

  • Abbott Laboratories
  • AngioDynamics
  • Boston Scientific Corporation
  • BTG International Ltd.
  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc
  • Merit Medical Systems
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pentax Medical(HOYA Corporation)
  • Salix Pharmaceuticals
  • STERIS plc
  • Teleflex Incorporated
  • US Medical Innovations, LLC

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.31

Global Gastrointestinal Bleeding Treatment Market to Reach US$1.2 Billion by 2030

The global market for Gastrointestinal Bleeding Treatment estimated at US$845.9 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Endoscopic Hemostatic Devices, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$704.8 Million by the end of the analysis period. Growth in the Closure Devices segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$230.5 Million While China is Forecast to Grow at 9.0% CAGR

The Gastrointestinal Bleeding Treatment market in the U.S. is estimated at US$230.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$238.8 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Gastrointestinal Bleeding Treatment Market - Key Trends & Drivers Summarized

Why Is Gastrointestinal Bleeding Treatment Becoming More Advanced and Effective?

Gastrointestinal (GI) bleeding treatment has evolved significantly in recent years, driven by advancements in diagnostic techniques, minimally invasive procedures, and targeted pharmacological therapies. GI bleeding, which can occur in the upper or lower digestive tract, is a serious medical condition that requires prompt diagnosis and intervention to prevent life-threatening complications. The most common causes include peptic ulcers, diverticulosis, inflammatory bowel disease (IBD), esophageal varices, and colorectal cancer.

The increasing prevalence of GI disorders, coupled with the aging global population, has heightened the demand for effective treatment solutions. Endoscopic hemostasis techniques, such as clip placement, argon plasma coagulation (APC), and injection therapy, have become the gold standard for controlling active bleeding in most cases. Additionally, the integration of artificial intelligence (AI) in endoscopic imaging has enhanced the early detection of bleeding sources, improving patient outcomes. As healthcare providers continue to adopt advanced treatment modalities, the landscape of GI bleeding management is shifting toward faster, safer, and more efficient interventions.

Which Treatment Modalities Are Driving Innovation in Gastrointestinal Bleeding Management?

The management of gastrointestinal bleeding has been revolutionized by a combination of endoscopic, pharmacological, and surgical interventions. Endoscopic procedures remain the primary treatment approach for acute GI bleeding, with techniques such as thermal coagulation, band ligation, and hemostatic spray technology providing immediate hemostasis. Capsule endoscopy and deep enteroscopy have also enhanced the ability to diagnose and treat obscure GI bleeding in the small intestine, an area previously difficult to access with conventional endoscopy.

Pharmacological treatments, including proton pump inhibitors (PPIs), vasoactive drugs, and tranexamic acid, play a crucial role in preventing rebleeding and managing underlying conditions. In severe cases, interventional radiology procedures such as transarterial embolization (TAE) are utilized to control bleeding when endoscopic methods fail. For patients with refractory GI bleeding, surgical intervention, including partial colectomy or gastrectomy, may be required. The growing adoption of combination therapy, integrating endoscopic and pharmacological treatments, has improved overall patient survival rates and reduced hospitalization costs.

How Are Technological Advancements Enhancing Gastrointestinal Bleeding Treatment?

Recent technological advancements have significantly improved the diagnosis, treatment, and prevention of gastrointestinal bleeding. AI-assisted endoscopy is one of the most transformative innovations, enabling real-time image analysis and automated detection of bleeding lesions. This technology enhances physician accuracy, reduces procedure times, and improves early detection of high-risk lesions. Additionally, the development of advanced hemostatic agents, including sprayable biologics and bioabsorbable hemostats, has expanded treatment options for complex bleeding cases.

Another breakthrough is the use of robotic-assisted endoscopic procedures, which offer greater precision and maneuverability in treating difficult-to-reach areas of the gastrointestinal tract. Smart capsule endoscopy has also gained traction, allowing for non-invasive visualization of the small intestine without the need for sedation or radiation exposure. Furthermore, advances in gene therapy and regenerative medicine are being explored to treat chronic GI conditions that predispose patients to recurrent bleeding episodes. These technological innovations are reshaping the future of GI bleeding management, enhancing both patient outcomes and healthcare efficiency.

What Factors Are Fueling the Growth of the Gastrointestinal Bleeding Treatment Market?

The growth in the gastrointestinal bleeding treatment market is driven by several factors, including the rising prevalence of GI disorders, increasing adoption of advanced endoscopic techniques, and the expansion of minimally invasive treatment options. The aging population, particularly in developed nations, has led to a higher incidence of peptic ulcers, diverticulosis, and esophageal varices, all of which contribute to GI bleeding cases.

Technological innovations, such as AI-assisted endoscopy, robotic procedures, and hemostatic biomaterials, have enhanced the effectiveness of GI bleeding treatment, prompting greater adoption by healthcare providers. The expansion of outpatient and ambulatory surgical centers has also increased patient access to minimally invasive procedures, reducing the need for hospitalization. Additionally, government initiatives promoting early screening and diagnostic programs for colorectal cancer and GI disorders have further fueled market growth. As the demand for effective and less invasive GI bleeding treatments continues to rise, the market is expected to expand, driven by continuous advancements in medical technology and patient-centered care solutions.

SCOPE OF STUDY:

The report analyzes the Gastrointestinal Bleeding Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Endoscopic Hemostatic Devices, Closure Devices, Other Products); GI Tract Division (Upper GI Tract, Lower GI Tract); Onset (Acute Onset, Chronic Onset); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • AngioDynamics
  • Boston Scientific Corporation
  • BTG International Ltd.
  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc
  • Merit Medical Systems
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pentax Medical (HOYA Corporation)
  • Salix Pharmaceuticals
  • STERIS plc
  • Teleflex Incorporated
  • US Medical Innovations, LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gastrointestinal Bleeding Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of GI Disorders and Aging Population Drive Demand for Gastrointestinal Bleeding Treatments
    • Advancements in Endoscopic Technologies Improve Early Detection and Targeted GI Bleed Management
    • Growth in Hospital and Ambulatory Endoscopy Procedures Fuels Market for Therapeutic Devices and Drugs
    • Increased Use of Hemostatic Clips, Sprays, and Energy Devices Expands Non-Surgical GI Bleeding Treatment Options
    • Greater Awareness of GI Complications from NSAIDs and Anticoagulants Spurs Prophylactic and Acute Care Demand
    • Rising Incidence of Peptic Ulcer Disease and Variceal Bleeding Enhances Demand for Endoscopic Intervention
    • Expansion of GI Care Centers and Digestive Disease Clinics Strengthens Access to Specialized Treatment
    • OEM Innovation in Disposable and Single-Use Endoscopic Tools Reduces Infection Risk and Streamlines Workflow
    • Growing Focus on Minimally Invasive GI Bleeding Therapies Enhances Recovery Outcomes and Hospital Throughput
    • Increased Adoption of Capsule Endoscopy and Imaging Enhances Early Bleeding Source Identification
    • Post-Pandemic Focus on GI Health Awareness and Telehealth Triage Strengthens Market for Rapid Response Treatments
    • Wider Use of Combination Therapies Involving Endoscopy and Pharmacologic Agents Improves Efficacy
    • Rising Demand for GI Bleed Treatments in Emergency and ICU Settings Expands Critical Care Application Scope
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gastrointestinal Bleeding Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gastrointestinal Bleeding Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gastrointestinal Bleeding Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Endoscopic Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Endoscopic Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Endoscopic Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Upper GI Tract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Upper GI Tract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Upper GI Tract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Lower GI Tract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Lower GI Tract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Lower GI Tract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Acute Onset by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Acute Onset by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Acute Onset by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Chronic Onset by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Chronic Onset by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Chronic Onset by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • JAPAN
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • CHINA
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • EUROPE
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Gastrointestinal Bleeding Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • FRANCE
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • GERMANY
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • INDIA
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Gastrointestinal Bleeding Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Gastrointestinal Bleeding Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030
  • AFRICA
    • Gastrointestinal Bleeding Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Gastrointestinal Bleeding Treatment by Product - Endoscopic Hemostatic Devices, Closure Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Gastrointestinal Bleeding Treatment by Product - Percentage Breakdown of Value Sales for Endoscopic Hemostatic Devices, Closure Devices and Other Products for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Gastrointestinal Bleeding Treatment by End-Use - Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Gastrointestinal Bleeding Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Users, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Gastrointestinal Bleeding Treatment by GI Tract Division - Upper GI Tract and Lower GI Tract Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Gastrointestinal Bleeding Treatment by GI Tract Division - Percentage Breakdown of Value Sales for Upper GI Tract and Lower GI Tract for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Gastrointestinal Bleeding Treatment by Onset - Acute Onset and Chronic Onset Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Gastrointestinal Bleeding Treatment by Onset - Percentage Breakdown of Value Sales for Acute Onset and Chronic Onset for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제